Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding*

Post-translational modifications (PTMs) can have profound effects on protein structure and protein dynamics and thereby can influence protein function. To understand and connect PTM-induced functional differences with any resulting conformational changes, the conformational changes must be detected and localized to specific parts of the protein. We illustrate these principles here with a study of the functional and conformational changes that accompany modifications to a monoclonal immunoglobulin γ1 (IgG1) antibody. IgG1s are large and heterogeneous proteins capable of incorporating a multiplicity of PTMs both in vivo and in vitro. For many IgG1s, these PTMs can play a critical role in affecting conformation, biological function, and the ability of the antibody to initiate a potential adverse biological response. We investigated the impact of differential galactosylation, methionine oxidation, and fucosylation on solution conformation using hydrogen/deuterium exchange mass spectrometry and probed the effects of IgG1 binding to the FcγRIIIa receptor. The results showed that methionine oxidation and galactosylation both impact IgG1 conformation, whereas fucosylation appears to have little or no impact to the conformation. FcγRIIIa binding was strongly influenced by both the glycan structure/composition (namely galactose and fucose) and conformational changes that were induced by some of the modifications.

[1]  T. Wales,et al.  Hydrogen exchange mass spectrometry for the analysis of protein dynamics. , 2006, Mass spectrometry reviews.

[2]  Y. Lyubarskaya,et al.  Determination of protein oxidation by mass spectrometry and method transfer to quality control. , 2006, Journal of chromatography. A.

[3]  R. Colbran,et al.  Oxidation of calmodulin alters activation and regulation of CaMKII. , 2007, Biochemical and biophysical research communications.

[4]  R. Huber,et al.  The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. , 2000, Nature.

[5]  Yoshiki Yamaguchi,et al.  Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. , 2007, Journal of molecular biology.

[6]  Roy Jefferis,et al.  Glycosylation as a strategy to improve antibody-based therapeutics , 2009, Nature Reviews Drug Discovery.

[7]  A K Patel,et al.  The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. , 1995, Molecular immunology.

[8]  Mark P Foster,et al.  Solution NMR of large molecules and assemblies. , 2007, Biochemistry.

[9]  Thomayant Prueksaritanont,et al.  Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. , 2009, Molecular immunology.

[10]  Benjamin A. Shoemaker,et al.  Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Smith,et al.  Mass spectrometric determination of isotopic exchange rates of amide hydrogens located on the surfaces of proteins. , 1996, Analytical chemistry.

[12]  J. R. Engen,et al.  Semi-automated data processing of hydrogen exchange mass spectra using HX-Express , 2006, Journal of the American Society for Mass Spectrometry.

[13]  John R Engen,et al.  High-speed and high-resolution UPLC separation at zero degrees Celsius. , 2008, Analytical chemistry.

[14]  R. Ghirlando,et al.  Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. , 2001, The Journal of biological chemistry.

[15]  A. Wlodawer,et al.  Determination of protein structures--a series of fortunate events. , 2008, Biophysical journal.

[16]  P. Carter.  Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.

[17]  Yoshiki Yamaguchi,et al.  Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. , 2006, Biochimica et biophysica acta.

[18]  R. Dwek,et al.  Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. , 1997, Biochemistry.

[19]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[20]  Robert Huber,et al.  The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex , 2000, Nature.

[21]  J. R. Engen,et al.  Analysis of protein complexes with hydrogen exchange and mass spectrometry. , 2003, The Analyst.

[22]  Thilo Stehle,et al.  Oxidizable Residues Mediating Protein Stability and Cytoprotective Interaction of DJ-1 with Apoptosis Signal-regulating Kinase 1* , 2009, Journal of Biological Chemistry.

[23]  B. Eipper,et al.  :Posttranslational Modification of Proteins: Expanding Nature's Inventory , 2008 .

[24]  S. Demarest,et al.  A broad range of Fab stabilities within a host of therapeutic IgGs. , 2007, Biochemical and biophysical research communications.

[25]  Stephen P. Young,et al.  Role of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding* , 2001, The Journal of Biological Chemistry.

[26]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[27]  R. Jefferis,et al.  IgG‐Fc‐mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation , 1998, Immunological reviews.

[28]  Gary Walsh,et al.  Post-translational modifications in the context of therapeutic proteins , 2006, Nature Biotechnology.

[29]  L. Kay,et al.  Solution NMR of supramolecular complexes: providing new insights into function , 2007, Nature Methods.

[30]  S. Iida,et al.  Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies , 2006, Expert opinion on biological therapy.

[31]  P. Rakowska,et al.  Physicochemical and biological assays for quality control of biopharmaceuticals: interferon alpha-2 case study. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[32]  John R. Engen,et al.  Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS. , 2009, Analytical chemistry.

[33]  Kouhei Tsumoto,et al.  Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.

[34]  W. Burkitt,et al.  Assessment of the repeatability and reproducibility of hydrogen/deuterium exchange mass spectrometry measurements. , 2008, Rapid communications in mass spectrometry : RCM.

[35]  Christopher T. Walsh,et al.  Posttranslational Modification of Proteins: Expanding Nature's Inventory , 2005 .

[36]  M Goodall,et al.  The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. , 2000, Molecular immunology.

[37]  J. Mandell,et al.  Identification of protein-protein interfaces by decreased amide proton solvent accessibility. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Sun,et al.  Recognition of immunoglobulins by Fcgamma receptors. , 2002, Molecular immunology.

[39]  S. Berkowitz,et al.  Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry. , 2009, Analytical chemistry.

[40]  R. Huber,et al.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. , 2003, Journal of molecular biology.

[41]  J Fraser Glickman,et al.  A Comparison of ALPHAScreen, TR-FRET, and TRF as Assay Methods for FXR Nuclear Receptors , 2002, Journal of biomolecular screening.

[42]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[43]  P. Sun,et al.  Recognition of immunoglobulins by Fcγ receptors , 2002 .

[44]  Gert Vriend,et al.  Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.

[45]  Sylvie Garneau-Tsodikova,et al.  Protein posttranslational modifications: the chemistry of proteome diversifications. , 2005, Angewandte Chemie.

[46]  Johnny Gonzales,et al.  In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase. , 2005, Biotechnology and bioengineering.

[47]  C. Sautès-Fridman,et al.  The Structure of a Human Type III Fcγ Receptor in Complex with Fc* , 2001, The Journal of Biological Chemistry.

[48]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[49]  Pauline M Rudd,et al.  The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.

[50]  L. Johnson,et al.  The effects of phosphorylation on the structure and function of proteins. , 1993, Annual review of biophysics and biomolecular structure.

[51]  Da Ren,et al.  Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. , 2008, Biochemistry.

[52]  Colleen E. Price,et al.  Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[53]  Zhongqi Zhang,et al.  Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry. , 1997, Journal of mass spectrometry : JMS.